Hutch News

Molecular mechanisms of late cancer relapse

Molecular mechanisms of late cancer relapse

from the Chapuis lab, Clinical Research Division
Science SpotlightOctober 15, 2018
Cancer cells evade immunotherapy by hiding telltale marker, suggesting how to stop relapse

Cancer cells evade immunotherapy by hiding telltale marker, suggesting how to stop relapse

A Nature Communications report explains why some Merkel cell carcinoma patients treated with immunotherapy see their cancers shrink at first but then come back.
News ReleasesSeptember 24, 2018
Triple therapy for rare skin cancer shows promise in small, early-stage trial

Triple therapy for rare skin cancer shows promise in small, early-stage trial

Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma
Hutch NewsMay 31, 2017
Immunotherapy shows promise in preventing leukemia relapse

Immunotherapy shows promise in preventing leukemia relapse

Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission
News ReleasesDecember 05, 2016